{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T16:05:46Z","timestamp":1792253146210,"version":"4.4.0"},"reference-count":107,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,8,27]],"date-time":"2018-08-27T00:00:00Z","timestamp":1535328000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"DOI":"10.3389\/fmed.2018.00236","type":"journal-article","created":{"date-parts":[[2018,8,27]],"date-time":"2018-08-27T05:58:04Z","timestamp":1535349484000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":121,"title":["Extracorporeal Photopheresis\u2014An Overview"],"prefix":"10.3389","volume":"5","author":[{"given":"Ara","family":"Cho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Jantschitsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Knobler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,8,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1056\/NEJM198702053160603","article-title":"Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy","volume":"316","author":"Edelson","year":"1987","journal-title":"N Engl J Med."},{"key":"B2","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/BF00371613","article-title":"Cytogenetic effects during extracorporeal photopheresis treatment of two patients with cutaneous T-cell lymphoma","volume":"283","author":"Peterseim","year":"1991","journal-title":"Archiv Dermatol Res."},{"key":"B3","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1002\/jca.21627.","article-title":"American council on ECP (ACE): why now?","volume":"33","author":"Edelson","year":"2018","journal-title":"J Clin Apher."},{"key":"B4","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1046\/j.1365-2141.1999.01773.x","article-title":"Extracorporeal photopheresis induces apoptosis in the lymphocytes of cutaneous T-cell lymphoma and graft-versus-host disease patients","volume":"107","author":"Bladon","year":"1999","journal-title":"Br J Haematol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1159\/000018472","article-title":"Investigation of annexin V binding to lymphocytes after extracorporeal photoimmunotherapy as an early marker of apoptosis","volume":"201","author":"Gerber","year":"2000","journal-title":"Dermatology"},{"key":"B6","first-page":"107","article-title":"Effect of UVA and 8-methoxypsoralen, 4, 6, 4'-trimethylangelicin or chlorpromazine on apoptosis of lymphocytes and their recognition by monocytes","volume":"61","author":"Wolnicka-Glubisz","year":"2010","journal-title":"J Physiol Pharmacol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S1473-0502(02)00014-9","article-title":"Transimmunization, a novel approach for tumor immunotherapy","volume":"26","author":"Berger","year":"2018","journal-title":"Transf Apher Sci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1002\/1097-0215(200002)9999:9999<::AID-IJC1073>3.0.CO;2-R","article-title":"Induction of human tumor-loaded dendritic cells","volume":"91","author":"Berger","year":"2001","journal-title":"Int J Cancer"},{"key":"B9","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/j.1537-2995.2005.00670.x","article-title":"Maturation state of dendritic cells during the extracorporeal photopheresis and its relevance for the treatment of chronic graft-versus-host disease","volume":"46","author":"Spisek","year":"2006","journal-title":"Transfusion"},{"key":"B10","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1097\/TP.0b013e3181c6ffd3","article-title":"Photochemotherapy induces the apoptosis of monocytes without impairing their function","volume":"89","author":"Hannani","year":"2010","journal-title":"Transplantation"},{"key":"B11","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1111\/j.1365-2249.2007.03372.x","article-title":"In vitro treatment of monocytes with 8-methoxypsolaren and ultraviolet A light induces dendritic cells with a tolerogenic phenotype","volume":"148","author":"Legitimo","year":"2007","journal-title":"Clin Exp Immunol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1080\/10428190600581419","article-title":"Transimmunization for cutaneous T cell lymphoma: a Phase I study","volume":"47","author":"Girardi","year":"2006","journal-title":"Leuk Lymphoma"},{"key":"B13","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/1523-1747.ep12499907","article-title":"Extracorporeal photochemotherapy induces the production of tumor necrosis factor-alpha by monocytes: implications for the treatment of cutaneous T-cell lymphoma and systemic sclerosis","volume":"98","author":"Vowels","year":"1992","journal-title":"J Investig Dermatol."},{"key":"B14","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1046\/j.1365-2567.1997.00325.x","article-title":"Extracorporeal photochemotherapy restores Th1\/Th2 imbalance in patients with early stage cutaneous T-cell lymphoma","volume":"92","author":"Di","year":"1997","journal-title":"Immunology"},{"key":"B15","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1159\/000246076","article-title":"Extracorporeal photochemotherapy induces a significant increase in CD36+ circulating monocytes in patients with Mycosis fungoides","volume":"194","author":"Fimiani","year":"1997","journal-title":"Dermatology"},{"key":"B16","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1182\/blood-2002-01-0068","article-title":"Immunologic mechanisms of extracorporeal photochemotherapy in chronic graft-versus-host disease","volume":"100","author":"Gorgun","year":"2002","journal-title":"Blood"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1182\/blood.V98.5.1622","article-title":"Brief report Immunomodulatory effects of extracorporeal photochemotherapy in patients with extensive chronic graft-versus-host disease","volume":"98","author":"Alcindor","year":"2001","journal-title":"Blood"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1182\/blood-2007-11-125542","article-title":"Extracorporeal photopheresis reverses experimental graft-versus-host disease through regulatory T cells","volume":"112","author":"Gatza","year":"2008","journal-title":"Transplantation"},{"key":"B19","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1097\/01.tp.0000267785.52567.9c","article-title":"Extracorporeal photochemotherapy is accompanied by increasing levels of circulating CD4+CD25+GITR+Foxp3+CD62L+ functional regulatory T-cells in patients with graft-versus-host disease","volume":"84","author":"Biagi","year":"2007","journal-title":"Transplantation"},{"key":"B20","doi-asserted-by":"publisher","first-page":"5968","DOI":"10.4049\/jimmunol.174.10.5968","article-title":"Intravenous infusion of syngeneic apoptotic cells by photopheresis induces antigen-specific regulatory T cells","volume":"174","author":"Maeda","year":"2005","journal-title":"J Immunol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"3065","DOI":"10.4049\/JIMMUNOL.180.5.3065","article-title":"Phenotypic and functional characterization of ultraviolet radiation-induced regulatory T cells","volume":"180","author":"Maeda","year":"2008","journal-title":"J Immunol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"5956","DOI":"10.4049\/jimmunol.181.9.5956","article-title":"Experimental extracorporeal photopheresis inhibits the sensitization and effector phases of contact hypersensitivity via two mechanisms: generation of IL-10 and induction of regulatory T cells","volume":"181","author":"Maeda","year":"2008","journal-title":"J Immunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1182\/blood-2006-02-003996","article-title":"High donor FOXP3-positive regulatory T-cell (Treg) content is associated with a low risk of GVHD following HLA-matched allogeneic SCT","volume":"108","author":"Rezvani","year":"2006","journal-title":"Blood"},{"key":"B24","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1111\/j.1432-2277.2007.00462.x","article-title":"Correlation of the CD4+CD25high T-regulatory cells in recipients and their corresponding donors to acute GVHD","volume":"20","author":"Zhai","year":"2007","journal-title":"Transplant International."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1097\/01.tp.0000260140.04815.77","article-title":"Regulatory T-cells in the graft and the risk of acute graft-versus-host disease after allogeneic stem cell transplantation","volume":"83","author":"Wolf","year":"2007","journal-title":"Transplantation"},{"key":"B26","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.healun.2008.02.015","article-title":"Role for CD4+CD25+ T cells in inhibition of graft rejection by extracorporeal photopheresis","volume":"27","author":"George","year":"2018","journal-title":"J Heart Lung Transpl."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2013.07.049","article-title":"Primary cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome): part I","author":"Jawed","year":"2014","journal-title":"J Am Acad Dermatol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1111\/ijd.12121","article-title":"Extracorporeal photopheresis for the treatment of erythrodermic cutaneous T-cell lymphoma: a single center clinical experience with long-term follow-up data and a brief overview of the literature","volume":"52","author":"Quaglino","year":"2013","journal-title":"Int J Dermatol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"223.e1","DOI":"10.1016\/j.jaad.2013.08.033","article-title":"Primary cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome): part II","volume":"70","author":"Jawed","year":"2014","journal-title":"J Am Acad Dermatol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/j.1396-0296.2003.01646.x","article-title":"The treatment of cutaneous T-cell lymphoma with photopheresis","volume":"16","author":"Zic","year":"2003","journal-title":"Dermatol Ther."},{"key":"B31","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1111\/bjh.14537","article-title":"The role of extracorporeal photopheresis in the management of cutaneous T-cell lymphoma, graft-versus-host disease and organ transplant rejection: a consensus statement update from the UK Photopheresis Society","volume":"177","author":"Alfred","year":"2017","journal-title":"Br J Haematol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s11912-018-0678-x","article-title":"Systemic treatment options for advanced-stage mycosis fungoides and sezary syndrome","volume":"20","author":"Photiou","year":"2018","journal-title":"Curr Oncol Rep."},{"key":"B33","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1093\/annonc\/mdx352","article-title":"Global patterns of care in advanced stage mycosis fungoides\/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium","volume":"28","author":"Quaglino","year":"2017","journal-title":"Ann Oncol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/jdv.12311","article-title":"Guidelines on the use of extracorporeal photopheresis","volume":"28","author":"Knobler","year":"2014","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1056\/NEJM199907013410103","article-title":"Long-term survival and late deaths after allogeneic bone marrow transplantation","volume":"341","author":"Socie","year":"1999","journal-title":"N Engl J Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","article-title":"National institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I","volume":"11","author":"Filipovich","year":"2005","journal-title":"Biol Blood Marr Transpl."},{"key":"B37","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I","volume":"21","author":"Jagasia","year":"2015","journal-title":"Biol Blood Marr Transpl."},{"key":"B38","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1177\/2040620717741860","article-title":"New and emerging therapies for acute and chronic graft versus host disease","volume":"9","author":"Hill","year":"2018","journal-title":"Ther Adv Hematol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.1182\/blood-2016-06-715284","article-title":"Ibrutinib efficacy and tolerability in patients with relapsed chronic lymphocytic leukemia following allogeneic HCT","volume":"128","author":"Ryan","year":"2016","journal-title":"Blood"},{"key":"B40","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.transci.2017.01.006","article-title":"Extra corporeal photochemotherapy in steroid refractory graft versus host disease: a review of guidelines and recommendations","volume":"56","author":"Mohammadi","year":"2017","journal-title":"Transf Apher Sci."},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000001466","article-title":"Extracorporeal photopheresis for treatment of acute and chronic graft versus host disease: an Italian multicentric retrospective analysis on 94 patients on behalf of the gruppo Italiano trapianto di midollo osseo","author":"Malagola","year":"2016","journal-title":"Transplantation"},{"key":"B42","doi-asserted-by":"publisher","first-page":"105","DOI":"10.2147\/PPA.S76563","article-title":"Systematic review and meta-analysis of prospective studies for ECP treatment in patients with steroid-refractory acute GVHD","volume":"9","author":"Zhang","year":"2015","journal-title":"Patient Pref Adher."},{"key":"B43","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1080\/10428194.2017.1361034","article-title":"Earlier may be better: the role of extracorporeal photopheresis (ECP) as prevention of GVHD after allogeneic transplant","volume":"59","author":"Choe","year":"2018","journal-title":"Leuk lymphoma"},{"key":"B44","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1080\/10428194.2017.1334120","article-title":"Extracorporeal photopheresis for GVHD prophylaxis after reduced intensity conditioning allogeneic hematopoietic stem cell transplantation: a prospective multicenter phase 2 study","volume":"59","author":"Michallet","year":"2018","journal-title":"Leuk Lymphoma"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-017-0662-8","article-title":"Photopheresis: advances and use in systemic sclerosis","author":"Zhou","year":"2017","journal-title":"Curr Rheumatol Rep."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1056\/NEJMra0806188","article-title":"Scleroderma","volume":"360","author":"Gabrielli","year":"2009","journal-title":"N Engl J Med."},{"key":"B47","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3109\/03009742.2010.528021","article-title":"Altered T-cell and regulatory cell repertoire in patients with diffuse cutaneous systemic sclerosis","volume":"40","author":"Papp","year":"2011","journal-title":"Scand J Rheumatol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"e5903","DOI":"10.1371\/journal.pone.0005903","article-title":"The pronounced Th17 profile in systemic sclerosis (SSc) together with intracellular expression of TGF\u03b2 and IFN\u03b3 distinguishes SSc phenotypes","volume":"4","author":"Radstake","year":"2009","journal-title":"PLoS ONE"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1111\/j.1365-2133.2010.09633.x","article-title":"Regulatory T cells in the skin lesions and blood of patients with systemic sclerosis and morphoea","volume":"162","author":"Antiga","year":"2010","journal-title":"Br J Dermatol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s13555-016-0136-3","article-title":"Phototherapy in scleroderma","volume":"6","author":"Hassani","year":"2016","journal-title":"Dermatol Ther."},{"key":"B51","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1001\/archdermatol.2008.547","article-title":"Extracorporeal photochemotherapy for generalized deep morphea","volume":"145","author":"Neustadter","year":"2009","journal-title":"Archiv Dermatol."},{"key":"B52","doi-asserted-by":"crossref","first-page":"3","DOI":"10.5070\/D3201021258","article-title":"Generalized morphea successfully treated with extracorporeal photochemotherapy (ECP)","volume":"20","author":"Pileri","year":"2014","journal-title":"Dermatol Online J."},{"key":"B53","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1159\/000017927","article-title":"Management of severe scleroderma with long-term extracorporeal photopheresis","volume":"196","author":"Krasagakis","year":"1998","journal-title":"Dermatology"},{"key":"B54","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s004030050166","article-title":"Three cases of progressive systemic sclerosis treated with extracorporeal photochemotherapy","volume":"289","author":"Fimiani","year":"1997","journal-title":"Archiv. Dermatol. Res."},{"key":"B55","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1365-4362.1993.tb02811.x","article-title":"Extracorporeal photochemotherapy in progressive systemic sclerosis","volume":"32","author":"Di","year":"1993","journal-title":"Int J Dermatol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.clim.2011.09.014","article-title":"Immunomodulatory effects of extracorporeal photochemotherapy in systemic sclerosis","volume":"142","author":"Papp","year":"2012","journal-title":"Clin Immunol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.jaad.2006.08.043","article-title":"Extracorporeal photopheresis in systemic sclerosis: effects on organ involvement?","volume":"56","author":"Reich","year":"2018","journal-title":"J Am Acad Dermatol."},{"key":"B58","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1001\/archderm.1992.01680130051005","article-title":"Treatment of systemic sclerosis with extracorporeal photochemotherapy","volume":"128","author":"Rook","year":"1992","journal-title":"Archiv Dermatol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.jaad.2005.11.1091","article-title":"A randomized, double-blind, placebo-controlled trial of photopheresis in systemic sclerosis","volume":"54","author":"Knobler","year":"2006","journal-title":"J Am Acad Dermatol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1034\/j.1600-0781.2000.160505.x","article-title":"Extended extracorporeal photochemotherapy with extracorporeal administration of 8-methoxypsoralen in systemic sclerosis","volume":"16","author":"Muellegger","year":"2000","journal-title":"Photodermatol Photoimmunol Photomed."},{"key":"B61","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1111\/phpp.12155","article-title":"Incidence of lung cancer in patients with systemic sclerosis treated with extracorporeal photopheresis","volume":"31","author":"Sabriye","year":"2015","journal-title":"Photodermatol Photoimmunol Photomed."},{"key":"B62","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1002\/jca.21276","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice\u2014evidence-based approach from the writing committee of the American Society for Apheresis: the sixth special issue","volume":"28","author":"Schwartz","year":"2013","journal-title":"J Clin Apher."},{"key":"B63","year":"2017","journal-title":"ET Yearly Statistics Overview - 2017"},{"key":"B64","first-page":"II242","article-title":"Photopheresis versus corticosteroids in the therapy of heart transplant rejection","volume":"86","author":"Costanzo-Nordin","year":"1992","journal-title":"Circulation"},{"key":"B65","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1097\/00007890-199204000-00021","article-title":"Successful treatment of heart transplant rejection with photopheresis","volume":"53","author":"Costanzo-Nordin","year":"1992","journal-title":"Transplantation"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1056\/NEJM199812103392404","article-title":"Photopheresis for the prevention of rejection in cardiac transplantation","volume":"339","author":"Barr","year":"1998","journal-title":"N Engl J Med."},{"key":"B67","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.healun.2005.10.004","article-title":"Rejection with hemodynamic compromise: objective evidence for efficacy of photopheresis","volume":"25","author":"Kirklin","year":"2018","journal-title":"J Heart Lung Transpl."},{"key":"B68","doi-asserted-by":"publisher","first-page":"927","DOI":"10.2217\/imt.14.69","article-title":"Extracorporeal photopheresis after heart transplantation","volume":"6","author":"Barten","year":"2014","journal-title":"Immunotherapy"},{"key":"B69","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.transci.2017.07.009","article-title":"Extracorporeal photochemotherapy in heart transplant rejection: A single-center experience","volume":"56","author":"Savignano","year":"2017","journal-title":"Transf Apher. Sci."},{"key":"B70","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1034\/j.1399-0012.2000.140211.x","article-title":"Prophylactic photopheresis and chronic rejection: effects on graft intimal hyperplasia in cardiac transplantation","volume":"14","author":"Barr","year":"2000","journal-title":"Clin Transpl."},{"key":"B71","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1097\/TP.0b013e31818bc024","article-title":"Extracorporeal photopheresis after lung transplantation: a 10-year single-center experience","volume":"86","author":"Benden","year":"2008","journal-title":"Transplantation"},{"key":"B72","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/j.healun.2012.05.002","article-title":"A prospective interventional study on the use of extracorporeal photopheresis in patients with bronchiolitis obliterans syndrome after lung transplantation","volume":"31","author":"Jaksch","year":"2018","journal-title":"J Heart Lung Transpl."},{"key":"B73","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1111\/ajt.12155","article-title":"Phenotyping established chronic lung allograft dysfunction predicts extracorporeal photopheresis response in lung transplant patients","volume":"13","author":"Greer","year":"2013","journal-title":"Am J Transpl."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1097\/TP.0000000000002168","article-title":"Extracorporeal photpheresis for bronchiolitis obliterans syndrome after lung transplantation","volume":"102","author":"Hachem","year":"2018","journal-title":"Transplantation"},{"key":"B75","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1097\/00054725-200207000-00002","article-title":"Long-term evolution of disease behavior of Crohn' s Disease","volume":"8","author":"Cosnes","year":"2002","journal-title":"Inflamm Bowel Dis."},{"key":"B76","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.cell.2010.01.023","article-title":"Homeostasis and inflammation in the intestine","volume":"140","author":"Garrett","year":"2010","journal-title":"Cell"},{"key":"B77","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.crohns.2009.12.002","article-title":"The second European evidence-based consensus on the diagnosis and management of Crohn's disease: current management","volume":"4","author":"Dignass","year":"2010","journal-title":"J Crohns Colitis"},{"key":"B78","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1046\/j.1365-2036.2001.01054.x","article-title":"Extracorporeal photochemotherapy in patients with steroid-dependent Crohn's disease: a prospective pilot study","volume":"15","author":"Reinisch","year":"2001","journal-title":"Aliment Pharmacol Ther."},{"key":"B79","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1002\/ibd.20833","article-title":"Extracorporeal photopheresis for the treatment of refractory Crohn's disease: results of an open-label pilot study","volume":"15","author":"Abreu","year":"2009","journal-title":"Inflamm Bowel Dis."},{"key":"B80","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/ibd.23012","article-title":"Extracorporeal Photopheresis (ECP) in patients with steroid-dependent Crohn's Disease: an open-label, multi-center, prospective trial","volume":"19","author":"Reinisch","year":"2013","journal-title":"Inflamm Bowel Dis."},{"key":"B81","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1002\/jca.21275","article-title":"Extracorporeal photopheresis for the treatment of severe, refractory steroid dependent pediatric Crohn's Disease","volume":"28","author":"Alexandra","year":"2013","journal-title":"J Clin Apher."},{"key":"B82","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1136\/adc.85.2.149","article-title":"Photopheresis at onset of type 1 diabetes: a randomised, double blind, placebo controlled trial","volume":"85","author":"Ludvigsson","year":"2001","journal-title":"Archiv Dis Child."},{"key":"B83","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1111\/j.1346-8138.2009.00706.x","article-title":"Guidelines for management of atopic dermatitis","volume":"36","author":"Saeki","year":"2009","journal-title":"J Dermatol."},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1111\/j.1610-0387.2009.06972.x","article-title":"Neurodermitis S2-Leitlinie","author":"Thomas","year":"2008","journal-title":"JDDG: J Deuts Dermatol Gesellsch."},{"key":"B85","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/j.1468-3083.2009.03415.x","article-title":"ETFAD\/EADV eczema task force 2009 position paper on diagnosis and treatment of atopic dermatitis","volume":"24","author":"Darsow","year":"2010","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1038\/jid.2008.283","article-title":"A role for Th17 cells in the immunopathogenesis of atopic dermatitis?","volume":"128","author":"Cesare","year":"2008","journal-title":"J Investig Dermatol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/j.jaci.2009.04.003","article-title":"Development and function of TH17 cells in health and disease","volume":"123","author":"Louten","year":"2009","journal-title":"J Allergy Clin Immunol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1056\/NEJMoa1314768","article-title":"Dupilumab treatment in adults with moderate-to-severe atopic dermatitis","volume":"371","author":"Beck","year":"2014","journal-title":"N Engl J Med."},{"key":"B89","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1007\/s40265-017-0768-3","article-title":"Dupilumab: first global approval","volume":"77","author":"Shirley","year":"2017","journal-title":"Drugs"},{"key":"B90","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/BF00370718","article-title":"Treatment of severe atopic dermatitis with extracorporeal photopheresis","volume":"287","author":"Prinz","year":"1994","journal-title":"Archiv Dermatol Res."},{"key":"B91","doi-asserted-by":"publisher","first-page":"635","DOI":"10.2340\/00015555-0952","article-title":"A retrospective study of six cases of severe recalcitrant atopic dermatitis treated with long-term extracorporeal photopheresis","volume":"90","author":"Hjuler","year":"2010","journal-title":"Acta Derm Venereol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/S0190-9622(99)70167-2","article-title":"Quality of life improvement in a patient with severe atopic dermatitis treated with photopheresis","volume":"40","author":"Mohla","year":"1999","journal-title":"J Am Acad Dermatol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1039\/C2PP25203A","article-title":"Extracorporeal photochemotherapy as systemic monotherapy of severe, refractory atopic dermatitis: results from a prospective trial","volume":"12","author":"Wolf","year":"2013","journal-title":"Photochem Photobiol Sci."},{"key":"B94","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/S0190-9622(99)70440-8","article-title":"Long-term application of extracorporeal photochemotherapy in severe atopic dermatitis","volume":"40","author":"Prinz","year":"1999","journal-title":"J Am Acad Dermatol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1111\/j.1346-8138.2004.tb00638.x","article-title":"Bicentre experience in the treatment of severe generalised atopic dermatitis with extracorporeal photochemotherapy","volume":"31","author":"Radenhausen","year":"2004","journal-title":"J Dermatol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1080\/00015550310002710","article-title":"Activation markers in severe atopic dermatitis following extracorporeal photochemotherapy","volume":"83","author":"Radenhausen","year":"2003","journal-title":"Acta Derm Venereol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/S0190-9622(98)70122-7","article-title":"Successful monotherapy of severe and intractable atopic dermatitis by photopheresis","volume":"38","author":"Richter","year":"1998","journal-title":"J Am Acad Dermatol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1159\/000104265","article-title":"Extracorporeal photopheresis as a treatment for patients with severe, refractory atopic dermatitis","volume":"215","author":"Sand","year":"2007","journal-title":"Dermatology"},{"key":"B99","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1111\/j.1468-3083.2012.04552.x","article-title":"Fimiani M","volume":"27","author":"Rubegni","year":"2013","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","author":"Diabetes","year":"1993","journal-title":"N Engl J Med."},{"key":"B101","doi-asserted-by":"publisher","first-page":"832","DOI":"10.2337\/diacare.26.3.832","article-title":"\u03b2-Cell function and the development of diabetes-related complications in the diabetes control and complications trial","volume":"26","author":"Steffes","year":"2003","journal-title":"Diabetes Care"},{"key":"B102","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1038\/ncpendmet0647","article-title":"The replication of \u03b2 cells in normal physiology, in disease and for therapy","volume":"3","author":"Butler","year":"2007","journal-title":"Nat Clin Pract Endocrinol Metab."},{"key":"B103","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1373\/clinchem.2010.148205","article-title":"Autoimmune markers in diabetes","volume":"57","author":"Winter","year":"2011","journal-title":"Clin Chem."},{"key":"B104","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1056\/NEJM198803173181103","article-title":"Factors associated with early remission of type I diabetes in children treated with cyclosporine","volume":"318","author":"Bougneres","year":"1988","journal-title":"N Engl J Med."},{"key":"B105","doi-asserted-by":"publisher","first-page":"2598","DOI":"10.1056\/NEJMoa043980","article-title":"Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes","volume":"352","author":"Keymeulen","year":"2005","journal-title":"N Engl J Med."},{"key":"B106","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1056\/NEJMoa0904452","article-title":"Rituximab, B-lymphocyte depletion, and preservation of beta-cell function","volume":"361","author":"Pescovitz","year":"2009","journal-title":"N Engl J Med."},{"key":"B107","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.clim.2010.01.01","article-title":"Experimental extracorporeal photopheresis therapy significantly delays the development of diabetes in non-obese diabetic mice","volume":"135","author":"Xia","year":"2010","journal-title":"Clin Immunol."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmed.2018.00236\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,30]],"date-time":"2022-08-30T06:43:49Z","timestamp":1661841829000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmed.2018.00236\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,27]]},"references-count":107,"alternative-id":["10.3389\/fmed.2018.00236"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2018.00236","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,27]]},"article-number":"236"}}